Outcomes | Aspirin group (n = 21) | Non-aspirin group (n = 42) | P value |
---|---|---|---|
Intraoperative blood loss (ml) | 257.1 ± 119.7 | 296.4 ± 280.8 | 0.540 |
Postoperative hemorrhagic events | 4 (19.0) | 7 (16.7) | > 0.999 |
Postoperative cerebral infarction | 6 (28.6) | 13 (31.0) | 0.846 |
Postoperative hospital stay (days) | 14.0 ± 5.4 | 14.5 ± 5.6 | 0.715 |
Functional outcome | 0.332 | ||
mRS < 3 | 13 (61.9) | 31 (73.8) | |
mRS ≥ 3 | 8 (38.1) | 11 (26.2) |